| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Quidel Corporation (NASDAQ:QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays a...
Morgan Stanley maintains Ortho Clinical Diagnostic (NASDAQ:OCDX) with a Equal-Weight and raises the price target from $16.9 t...
Ortho Clinical Diagnostic (NASDAQ:OCDX) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimat...
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per s...
-Reuters
Upgrades
Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)
Evercore ISI Group analyst Vijay Kumar upgrades Ortho Clinical Diagnostic (NASDAQ:OCDX) from In-Line to Outperform and annou...
Ortho Clinical Diagnostic (NASDAQ:OCDX) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:30 PM. Here'...